The following content is for educational purposes only, is intended for healthcare professionals, and does not supercede local clinical guidelines.
This page will contain downloadable educational resources and links to CaReMe guidelines for the care of patients with cardio-renal-metabolic disorders.
CaReMe UK guidance documents
Guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with Type 2 diabetes and atherosclerotic cardiovascular disease. Published 2020. Link
CaReMe UK Publications
- Guidelines in practice: Use a Combined Cardio–Renal–Metabolic Approach to Treat Cardiovascular Disease in Patients With Kidney Disease or Diabetes. https://www.medscape.co.uk/viewarticle/use-combined-cardio-renal-metabolic-approach-treat-2022a10029f1
- Rapid Response to: Rapid response to: SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline https://www.bmj.com/content/373/bmj.n1091/rr
- Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently. https://link.springer.com/article/10.1007/s13300-022-01242-y
- Guidelines in Practice: Manage Diabetes and Comorbidities with a Joined-Up Strategy https://www.medscape.co.uk/viewarticle/manage-diabetes-and-comorbidities-joined-strategy-2022a10017xk
- Guidelines in Practice: Patient Scenarios: CaReMeUK Guidance on the Management of Diabetes and Comorbidities. https://www.medscape.co.uk/viewarticle/patient-scenarios-caremeuk-guidance-management-diabetes-and-2023a10002qu